Veracyte, Inc.
VCYT
$59.00
$2.243.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 307.36% | 704.79% | 26.28% | -117.09% | 478.06% |
| Total Depreciation and Amortization | 1.27% | -15.27% | -10.41% | -4.34% | -4.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.74% | -96.13% | 54.91% | 126.59% | -26.46% |
| Change in Net Operating Assets | 19.14% | 242.43% | 7,110.99% | -78.87% | 36.48% |
| Cash from Operations | 556.75% | 114.41% | 49.37% | 13.63% | 159.80% |
| Capital Expenditure | -62.84% | 8.72% | -24.53% | 53.57% | 14.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.00% | 102.39% | -- | -- | -- |
| Cash from Investing | -146.94% | 89.97% | 2,252.68% | 91.91% | -1,900.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -7.82% | 7.54% | -53.56% | 40.40% | -0.03% |
| Repurchase of Common Stock | 0.92% | -11.76% | -29.08% | -82.66% | -146.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.24% | 96.70% | -71.07% | -5,045.45% | -650.46% |
| Foreign Exchange rate Adjustments | -178.38% | 102.99% | -58.90% | 1,039.34% | 168.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.08% | 236.17% | 151.75% | 24.89% | -648.81% |